Former President Joe Biden has been diagnosed with an aggressive form of prostate cancer that has already spread to his bones, leading to renewed scrutiny over the effectiveness of his previous medical oversight and the transparency surrounding his health.
At 82, Biden reportedly began experiencing urinary symptoms that led to the discovery of a prostate nodule. Subsequent testing revealed a high Gleason score of 9, indicating a fast-growing and advanced form of the disease. While serious, doctors say the cancer remains hormone-sensitive, allowing for a range of treatment options.
What has surprised medical professionals is the late stage of the diagnosis, considering Biden’s routine access to healthcare as a former president. Some experts suggest the disease may have been present during his time in office, and that earlier detection through standard PSA testing could have been possible. These details have led to speculation about whether signs of the illness were missed—or even deliberately withheld.
Adding to the controversy, Donald Trump Jr. publicly questioned how such an advanced case could go undetected, hinting at the possibility of a cover-up. Biden’s team responded by affirming that the former president is stable and actively considering treatment plans with his doctors.
Amid the speculation, messages of support have poured in from both allies and opponents. President Kamala Harris praised Biden’s strength and determination, while Donald Trump also wished him a full and swift recovery. Biden acknowledged the overwhelming encouragement, saying he and his wife Jill draw strength from the challenges they face.
The diagnosis has reignited national discussion on the health of public officials, highlighting the need for regular screenings and greater openness with the American public.